Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease (2024)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FORLENZA, ORESTES VICENTE - FM ; FERREIRA, ANA FLAVIA FERNANDES - ICB
- Unidades: ICB; FM
- DOI: 10.1016/j.arr.2024.102231
- Subjects: FISIOLOGIA; DOENÇA DE ALZHEIMER; DOENÇA DE PARKINSON; LÍTIO; DOENÇAS NEURODEGENERATIVAS; REVISÃO SISTEMÁTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Elsevier Ireland Ltd.
- Publisher place: Shannon, Irlanda
- Date published: 2024
- Source:
- Título: Ageing Research Reviews
- ISSN: 1872-9649
- Volume/Número/Paginação/Ano: v. 95, art. 102231, 20 p., 2024
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SINGULANI, Monique Patricio et al. Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease. Ageing Research Reviews, v. 95, p. 20 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.arr.2024.102231. Acesso em: 27 dez. 2025. -
APA
Singulani, M. P., Ferreira, A. F. F., Figueroa, P. B. S., Cuyul-Vásquez, I., Talib, L. L., Forlenza, O. V., & Britto, L. R. G. de. (2024). Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease. Ageing Research Reviews, 95, 20 . doi:10.1016/j.arr.2024.102231 -
NLM
Singulani MP, Ferreira AFF, Figueroa PBS, Cuyul-Vásquez I, Talib LL, Forlenza OV, Britto LRG de. Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease [Internet]. Ageing Research Reviews. 2024 ; 95 20 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.arr.2024.102231 -
Vancouver
Singulani MP, Ferreira AFF, Figueroa PBS, Cuyul-Vásquez I, Talib LL, Forlenza OV, Britto LRG de. Lithium and disease modification: a systematic review and meta-analysis in Alzheimer's and Parkinson’s disease [Internet]. Ageing Research Reviews. 2024 ; 95 20 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.arr.2024.102231 - Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Mitochondrial abnormalities in neurological disorders
- Most utilized rodent models for Alzheimer’s and Parkinson’s disease: a critical review of the past 5 years
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- The role of interleukin-17 in neurological disorders
- Efeitos do exercício físico na função e biogênese mitocondrial em modelo de doença de Parkinson induzido por 6-hidroxidopamina
- Association between thyroid function and Alzheimer’s disease: a systematic review
Informações sobre o DOI: 10.1016/j.arr.2024.102231 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
